Barbara Balestrieri, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Group V Phospholipases A2 | 10 | 2020 | 25 | 3.040 |
Why?
|
| Macrophage Activation | 3 | 2021 | 558 | 1.630 |
Why?
|
| Macrophages | 11 | 2024 | 5655 | 1.340 |
Why?
|
| Pneumonia | 4 | 2024 | 2133 | 1.040 |
Why?
|
| Linoleic Acid | 1 | 2024 | 157 | 0.880 |
Why?
|
| Oxylipins | 1 | 2021 | 49 | 0.820 |
Why?
|
| Macrophages, Peritoneal | 2 | 2016 | 251 | 0.770 |
Why?
|
| Interleukin-4 | 3 | 2024 | 1147 | 0.750 |
Why?
|
| Phospholipases A2 | 4 | 2018 | 203 | 0.750 |
Why?
|
| Candida albicans | 2 | 2016 | 394 | 0.720 |
Why?
|
| Phospholipases A | 4 | 2006 | 216 | 0.650 |
Why?
|
| Alternaria | 1 | 2017 | 44 | 0.620 |
Why?
|
| Phagocytosis | 3 | 2016 | 1539 | 0.610 |
Why?
|
| Asthma, Aspirin-Induced | 1 | 2020 | 182 | 0.590 |
Why?
|
| Phospholipids | 1 | 2020 | 784 | 0.590 |
Why?
|
| Dinoprostone | 2 | 2017 | 600 | 0.570 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 1157 | 0.550 |
Why?
|
| Eosinophils | 2 | 2017 | 955 | 0.530 |
Why?
|
| Candidiasis | 2 | 2016 | 366 | 0.530 |
Why?
|
| Hypersensitivity | 3 | 2019 | 1102 | 0.530 |
Why?
|
| Lectins, C-Type | 2 | 2016 | 588 | 0.510 |
Why?
|
| Transglutaminases | 1 | 2016 | 194 | 0.500 |
Why?
|
| Phospholipases A2, Secretory | 2 | 2010 | 31 | 0.470 |
Why?
|
| Fatty Acids | 1 | 2021 | 1809 | 0.460 |
Why?
|
| Nasal Polyps | 1 | 2016 | 360 | 0.380 |
Why?
|
| Zymosan | 3 | 2009 | 124 | 0.370 |
Why?
|
| Phagosomes | 2 | 2009 | 193 | 0.370 |
Why?
|
| Pyroglyphidae | 1 | 2010 | 88 | 0.360 |
Why?
|
| Eicosanoids | 3 | 2006 | 279 | 0.360 |
Why?
|
| Lymphocytes | 1 | 2017 | 2617 | 0.350 |
Why?
|
| Inflammation | 5 | 2022 | 10638 | 0.330 |
Why?
|
| Arachidonic Acid | 1 | 2006 | 434 | 0.250 |
Why?
|
| Receptors, Purinergic P2 | 2 | 2019 | 153 | 0.250 |
Why?
|
| Immunity | 3 | 2021 | 1012 | 0.250 |
Why?
|
| Lung | 3 | 2024 | 9856 | 0.240 |
Why?
|
| Asthma | 2 | 2022 | 6011 | 0.240 |
Why?
|
| Mice, Knockout | 9 | 2017 | 14557 | 0.230 |
Why?
|
| Mice | 16 | 2024 | 81183 | 0.190 |
Why?
|
| Cells, Cultured | 5 | 2020 | 19229 | 0.190 |
Why?
|
| Animals | 19 | 2024 | 168757 | 0.180 |
Why?
|
| Carnitine | 1 | 2020 | 246 | 0.170 |
Why?
|
| Dendritic Cells | 1 | 2010 | 2725 | 0.170 |
Why?
|
| Macrophages, Alveolar | 2 | 2019 | 407 | 0.170 |
Why?
|
| Respiratory Hypersensitivity | 2 | 2011 | 274 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 9 | 2019 | 21827 | 0.160 |
Why?
|
| Leukotrienes | 1 | 2019 | 255 | 0.160 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2017 | 40 | 0.150 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2017 | 41 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 783 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2009 | 2958 | 0.150 |
Why?
|
| Antigens, Dermatophagoides | 2 | 2019 | 100 | 0.140 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2016 | 103 | 0.140 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2017 | 402 | 0.140 |
Why?
|
| Signal Transduction | 3 | 2021 | 23403 | 0.130 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 844 | 0.130 |
Why?
|
| Cytokines | 2 | 2021 | 7322 | 0.130 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1782 | 0.120 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 1889 | 0.110 |
Why?
|
| Capillary Permeability | 2 | 2009 | 798 | 0.110 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2017 | 581 | 0.110 |
Why?
|
| Cyclic AMP | 1 | 2017 | 1472 | 0.110 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 1889 | 0.110 |
Why?
|
| Th2 Cells | 1 | 2017 | 1061 | 0.110 |
Why?
|
| Allergens | 3 | 2019 | 1320 | 0.100 |
Why?
|
| Lymphocyte Activation | 2 | 2013 | 5524 | 0.100 |
Why?
|
| Lipids | 1 | 2022 | 3305 | 0.100 |
Why?
|
| Leukotriene D4 | 1 | 2009 | 38 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2505 | 0.080 |
Why?
|
| Aspirin | 1 | 2020 | 3282 | 0.080 |
Why?
|
| Receptors, Leukotriene | 1 | 2009 | 123 | 0.080 |
Why?
|
| Antigen-Antibody Complex | 1 | 2010 | 517 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2024 | 10481 | 0.080 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2006 | 60 | 0.070 |
Why?
|
| Prostaglandin D2 | 1 | 2006 | 122 | 0.070 |
Why?
|
| Group II Phospholipases A2 | 1 | 2006 | 13 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2009 | 4462 | 0.070 |
Why?
|
| Cell Movement | 1 | 2017 | 5217 | 0.070 |
Why?
|
| Humans | 12 | 2022 | 744343 | 0.060 |
Why?
|
| Antigen Presentation | 1 | 2010 | 1284 | 0.060 |
Why?
|
| Golgi Apparatus | 1 | 2006 | 410 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2006 | 611 | 0.060 |
Why?
|
| Mitochondrial Proteins | 1 | 2010 | 996 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 12072 | 0.060 |
Why?
|
| Proteoglycans | 1 | 2006 | 835 | 0.060 |
Why?
|
| Endosomes | 1 | 2006 | 520 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.050 |
Why?
|
| Immune Tolerance | 1 | 2011 | 2258 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2009 | 1222 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2010 | 2440 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 2017 | 1866 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 1790 | 0.050 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2019 | 20 | 0.050 |
Why?
|
| Dermatophagoides farinae | 1 | 2019 | 25 | 0.050 |
Why?
|
| Protein Transport | 1 | 2006 | 1988 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11366 | 0.040 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2019 | 82 | 0.040 |
Why?
|
| Mast Cells | 1 | 2006 | 1544 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 4386 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2016 | 21746 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2019 | 768 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 4420 | 0.040 |
Why?
|
| Biological Assay | 1 | 2019 | 652 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 10180 | 0.030 |
Why?
|
| Survival Rate | 1 | 2009 | 12788 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 3712 | 0.030 |
Why?
|
| Protein Binding | 1 | 2006 | 9386 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2010 | 6386 | 0.030 |
Why?
|
| Ligands | 1 | 2019 | 3282 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2009 | 7880 | 0.030 |
Why?
|
| Dermatophagoides pteronyssinus | 1 | 2010 | 12 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 386 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 2011 | 455 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 56430 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 2216 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 9734 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2010 | 394 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 85781 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 390 | 0.020 |
Why?
|
| Male | 5 | 2019 | 350118 | 0.020 |
Why?
|
| Dust | 1 | 2010 | 482 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 3386 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 675 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 905 | 0.020 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 380 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2006 | 475 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4479 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 1655 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 163280 | 0.010 |
Why?
|
| Species Specificity | 1 | 2006 | 2478 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 213383 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 2699 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 214055 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2009 | 5179 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 1903 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 2010 | 2072 | 0.010 |
Why?
|
| Monocytes | 1 | 2009 | 2596 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 2513 | 0.010 |
Why?
|
| Kinetics | 1 | 2006 | 6473 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2009 | 5974 | 0.010 |
Why?
|
| Female | 5 | 2019 | 380194 | 0.010 |
Why?
|
| Calcium | 1 | 2009 | 5756 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 2751 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 18029 | 0.010 |
Why?
|